| 000 | 01087 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250515055812.0 | ||
| 264 | 0 | _c20070709 | |
| 008 | 200707s 0 0 eng d | ||
| 022 | _a0315-162X | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBhatia, Ajay | |
| 245 | 0 | 0 |
_aTumor necrosis factor (TNF) can paradoxically increase on etanercept treatment, occasionally contributing to TNF-mediated disease. _h[electronic resource] |
| 260 |
_bThe Journal of rheumatology _cFeb 2007 |
||
| 300 |
_a447-9; author reply 449-50 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 | _aContraindications |
| 650 | 0 | 4 | _aEtanercept |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xadverse effects |
| 650 | 0 | 4 |
_aPsoriasis _xchemically induced |
| 650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor _ximmunology |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 700 | 1 | _aKast, Richard E | |
| 773 | 0 |
_tThe Journal of rheumatology _gvol. 34 _gno. 2 _gp. 447-9; author reply 449-50 |
|
| 999 |
_c16863834 _d16863834 |
||